« Back to Record
Rothenberg, M. E., Roufosse, F., Faguer, S., Gleich, G. J., Steinfeld, J., Yancey, S. W., Mavropoulou, E., Kwon, N., & HES Mepolizumab Study Group, (2022). Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5. The journal of allergy and clinical immunology. In practice, 10(9), 2367-2374.e3. doi:10.1016/j.jaip.2022.04.037
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/355438



